No CrossRef data available.
Albrecht, Johan A. See Neyt
Albrecht, Johan A. See Neyt
Aldasoro, Elena, Adelina Pérez Alonso, Laureano Ribacoba, Santiago Esnaola, Maite Olaizola, Jose Antonio Carrera, Ana Bañuelos, and Rosa Rico. Assessing quality of end-of-life hospital care in a southern European regional health service, 464
Alicia, Pedro. See Lehoux
Allsup, S., M. Gosney, A. Haycox, and M. Regan. Cost–benefit evaluation of routine influenza immunization in people 65–74 years of age, 144
Alonso, Adelina Perez. See Aldasoro
Ament, André. See Evers
Anderberg, Bo. See Janson
Andersen, Henning Rud. See Terkelsen
Asadi-Lari, Mohsen, and David Gray. Health needs assessment tools: Progress and potential, 288
Aubry, David. See Paré
Austoker, J. See Bankhead
Awa, Aziz. See Porzsolt
Babazono, Akira, Motonobu Miyazaki, Takuya Imatoh, Hiroshi Une, Eiji Yamamoto, Toshihide Tsuda, Kiyoshi Tanaka, and Shinichi Tanihara. Effects of the increase in co-payments from 20 to 30 Percent on the compliance rate of patients with hypertension or diabetes mellitus in the employed health insurance system, 228
Backer Cave, Carolyn. See Shepherd
Bagust, A. See Boland
Baltussen, Rob, Werner Brouwer, and Louis Niessen. Cost-effectiveness analysis for priority setting in health: Penny-wise but pound-foolish, 532
Bankhead, C. R., J. Brett, C. Bukach, P. Webster, S. Stewart-Brown, M. Munafo, and J. Austoker. Impact of screening on future health-promoting behaviors and health beliefs: A systematic review, 147
Bañuelos, Ana. See Aldasoro
Bartlett, William. See Derrett
Barton, P. M. See Mant
Battista, Renaldo N. See Lehoux
Bentley, George. See Derrett
Berit, Wisløff. See Håheim
Beverley, C. See Pandor
Blamey, Stephen. See Weston
Blom, Marja. See Räsänen
Bloom, Bernard S. Effects of continuing medical education on improving physician clinical care and patient health: A review of systematic reviews, 380
Bloomfield, L. See Townsend
Boland, A., A. Haycox, A. Bagust, and L. Fitzsimmons. Randomized controlled trial to evaluate the clinical- and cost-effectiveness of Hickman line insertions in adult cancer patients by nurses, 145
Borgia, Piero. See Lehoux
Borgström, Fredrik. See Zethraeus
Boucher, Michel. See Kwok
Brady, Bruce K., Lynda McGahan, and Becky Skidmore. Systematic review of economic evidence on stroke rehabilitation services, 15
Brett, J. See Bankhead
Brodin, Håkan F. T. See Shepherd
Brophy, James M. See McGregor
Brophy, James M., and Lonny J. Erickson. Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada, 326
Brouwer, Werner. See Baltussen
Bukach, C. See Bankhead
Burdett, Sarah. See Michiels
Cadilhac, Dominique A. See Mihalopoulos
Cairns, J. See Wardlaw
Carlsson, Per. See Janson
Carrera, Jose Antonio. See Aldasoro
Carter, Robert C. See Mihalopoulos
Castelnuovo, Emanuela. See Stein
Cheung, Wai-Yee. See Hutchings
Chilcott, J. See Pandor
Chmielowiec, Chester. See Chuck
Chuck, Anderson, Philip Jacobs, Wayne Logus, Donald St. Hilaire, Chester Chmielowiec, and Alexander McEwan. The marginal cost of operating a positron emission tomography center in a regulatory environment, 442
Clarysse, Bart. See Neyt
Cocquyt, Véronique F. See Neyt
Cohen, David. See Hutchings
Cookson, B. D. See Cooper
Cooper, B. S., S. P. Stone, C. C. Kibbler, B. D. Cookson, J. A. Roberts, G. F. Medley, G. J. Duckworth, R. Lai, and S. Ebrahim. Systematic review of isolation policies in the hospital management of methicillinresistant Staphylococcus aureus: A review of the literature with epidemiological and economic modeling, 146
Corabian, Paula, David Hailey, Christa Harstall, Don Juzwishin, and Carmen Moga. Mentoring a developing health technology assessment initiative in Romania: An example for countries with limited experience of assessing health technology, 522
Coyle, Doug. See Lehoux
Coyte, Peter C. See Kopach
Currie, Craig J. See Dixon
Dalziel, Kim. See Stein
Davé, S. See Townsend
Davies, M. K. See Mant
Davies, R. C. See Mant
de Boer, Angela G. E. M. See Stalmeier
de Haes, Hanneke C. J. M. See Stalmeier
de Vet, Henrica. See Evers
Deeks, J. J. See Mant
Delaney, B. C. See Mant
Denis, Jean-Louis. See Hivon
Dennis, M. S. See Wardlaw
Derrett, Sarah, Elizabeth A. Stokes, Marilyn James, William Bartlett, and George Bentley. Cost and health status analysis after autologous chondrocyte implantation and mosaicplasty: A retrospective comparison, 359
Dewey, Helen M. See Mihalopoulos
Dijkstra, R. See Grimshaw
Dixon, Simon, Virge James, Daniel Hind, and Craig J. Currie. Economic analysis of the implementation of autologous transfusion technologies throughout England, 234
Dodd, Mary. See Elliott
Donaldson, C. See Grimshaw
Donnan, Geoffrey A. See Mihalopoulos
Draborg, Eva, and Dorte Gyrd-Hansen. Time-trends in health technology assessments: An analysis of developments in composition of international health technology assessments from 1989 to 2002, 492
Draborg, Eva, Dorte Gyrd-Hansen, Peter Bo Poulsen, and Mopens Horder. International comparison of the definition and the practical application of health technology assessment, 89
Drummond, Michael, Andrea Manca, and Mark Sculpher. Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies, 165
Drummond, Michael F. See Iglesias
Duckworth, G. J. See Cooper
Eastham, J. See Pandor
Ebrahim, S. See Cooper
Eccles, M. P. See Grimshaw
Elliott, Rachel A., Judith M. Thornton, A. Kevin Webb, Mary Dodd, and Mary P. Tully. Comparing costs of home versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center, 506
Eng, Ken. See Feeny
Eng, Ken. See Jones
Erickson, Lonny J. See Brophy
Esnaola, Santiago. See Aldasoro
Evans, Edward. See Oh
Evers, Silvia, Mariëlle Goossens, Henrica de Vet, Maurits van Tulder, and André Ament. Criteria list for assessment of methodological quality of economic evaluations: Consensus on health economic criteria, 240
Fässler, Margrit. See Porzsolt
Fauli, Siri, and Geir Thue. Decision making in general practice: The availability and use of a specific laboratory analysis, 386
Feeny, David. See Jones
Feeny, David, and Ken Eng. A test of prospect theory, 511
Fitzsimmons, L. See Boland
Fleurence, Rachael L. Cost-effectiveness of pressure-relieving devices for the prevention and treatment of pressure ulcers, 334
Flynn, Terry N., and Tim J. Peters. Cluster randomized trials: Another problem for cost-effectiveness Ratios, 403
Fraser, C. See Grimshaw
Gabbay, John. See Shepherd
Gallaway, Ian D. See Kopach
Gandjour, Afschin, Thomas Kerschbaum, Andreas Reis, and Karl Wilhelm Lauterbach. Technology assessment in dentistry: A comparison of the longevity and cost-effectiveness of inlays, 319
Garside, Ruth. See Stein
Geiger, Glen. See Kopach
Ginnelly, Laura. See Golder
Glanville, Julie. See Golder
Golder, Su, Julie Glanville, and Laura Ginnelly. Populating decision-analytic models: The feasibility and efficiency of database searching for individual parameters, 305
Gonzalez-Perez, Juan G., Luke Vale, Sally C. Stearns, and Sarah Wordsworth. Hemodialysis for end-stage renal disease: A cost-effectiveness analysis of treatment options, 32
Goodwin, Peter Charles, Julie Ratcliffe, and Matthew Charles Morrissey. Physiotherapy after arthroscopic partial meniscectomy surgery: An assessment of costs to the National Health Service, patients and society, 452
Goossens, Mariëlle. See Evers
Gosney, M. See Allsup
Granados, Alicia. Health-care management and the culture of assessment: An urgent liason?, 420
Granados, Gallo. See Lehoux
Gravelle, Hugh. See Richardson
Gray, David. See Asadi-Lari
Greenberg, Dan. See Sonnad
Greenberg, Dan, Yitzhak Peterburg, Daniel Vekstein, and Joseph S. Pliskin. Decisions to adopt new technologies at the hospital level: Insights from Israeli medical centers, 219
Grimshaw, J. M., R. E. Thomas, G. MacLennan, C. Fraser, C. R. Ramsay, L. Vale, P. Whitty, M. P., Eccles, L. Matowe, L. Shirran, M. Wensing, R., Dijkstra, and C. Donaldson. Effectiveness and efficiency of guideline dissemination and implementation strategies, 149
Gundgaard, Jens. See Olsen
Gyrd-Hansen, Dorte. See Draborg
Gyrd-Hansen, Dorte. See Draborg
Haglind, Eva. See Janson
Håheim, Lise Lund, Berit Mørland, Torbjørn Fosen Wisløff, and Anita Lyngstadaas. Six years' experience with interdisciplinary review teams in health technology assessment in Norway, 526
Hailey, David. See Corabian
Hailey, David, and Khai Tran. Quality and relevance of evidence in support of guideline recommendations for sleep laboratory investigations, 459
Hammersley, L. See Mant
Harstall, Christa. See Corabian
Haycox, A. See Allsup
Haycox, A. See Boland
Hayes, J. See Townsend
Henriksson, Peter. See Kiessling
Herzberger, Barbara. See Porzsolt
Hind, Daniel. See Dixon
Hivon, Myriam, Pascale Lehoux, Jean-Louis Denis, and Stéphanie Tailliez. Use of health technology assessment in decision making: Coresponsibility of users and producers?, 268
Hobbs, F. D. R. See Mant
Hofmann, Bjørn. Toward a Procedure for Integrating Moral Issues in Health Technology Assessment, 312
Horder, Mogens. See Draborg
Hutchings, Hayley A., Wai-Yee Cheung, John G. Williams, David Cohen, Mirella F. Longo, and Ian Russell. Can electronic routine data act as a surrogate for patient-assessed outcome measures?, 138
Iglesias, Cynthia P., Michael F. Drummond, and Joan Rovira. Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation, 1
Imanaka, Yuichi. See Oh
Imatoh, Takuya. See Babazono
Jacobs, Philip. See Chuck
Jackson, Terri J. See Weston
James, Marilyn. See Derrett
James, Virge. See Dixon
Janson, Martin, Per Carlsson, Eva Haglind, and Bo Anderberg. Data validation in an economic evaluation of surgery for colon cancer, 246
Jones, C. Allyson, David Feeny, and Ken Eng. Test-retest reliability of health utilities index scores: Evidence from hip fracture, 393
Jönsson, Bengt. See Lundkvist
Jönsson, Bengt. See Zethraeus
Jørgensen, Torben. See Olsen
Juzwishin, Don. See Corabian
Juzwishin, Don. See Wanke
Kaitelidou, Daphne, Panagiotis N. Ziroyanis, Nikolaos Maniadakis, and Lycurgus L. Liaropoulos. Economic evaluation of hemodialysis: Implications for technology assessment in Greece, 40
Kajnar, Hana. See Porzsolt
Kanis, John. See Zethraeus
Kattainen, Eija, Harri Sintonen, Raimo Kettunen, and Pirkko Meriläinen. Health-related quality of life of coronary artery bypass grafting and percutaneous transluminal coronary artery angioplasty patients: 1-Year follow-up, 172
Keir, S. L. See Wardlaw
Kerschbaum, Thomas. See Gandjour
Kettunen, Raimo. See Kattainen
Kibbler, C. C. See Cooper
Kiessling, Anna, Niklas Zethraeus, and Peter Henriksson. Cost of lipid lowering in patients with coronary artery disease by case method learning, 180
Kievit, Job. See van den Brink
Kildemoes, Helle Wallach, and Ivar Sønbø Kristiansen. Response to an optimistic viewpoint, 416
Kopach, Renata, Somayeh Sadat, Ian D. Gallaway, Glen Geiger, Wendy J. Ungar, and Peter C Coyte. Cost-effectiveness analysis of medical documentation alternatives, 126
Kristiansen, Ivar Sønbø. See Kildemoes
Kung, Pei-Tseng, Wen-Chen Tsai, Chih-Liang Yaung, and Kai-Ping Liao. Determinants of computed tomography and magnetic resonance imaging utilization in Taiwan, 81
Kwok, Lisa, Dana Molckovsky, and Michel Boucher. Ximelagatran: A new type of oral anticoagulant, 480
Ladelund, Steen. See Olsen
Lai, R. See Cooper
Lassen, Jens Flensted. See Terkelsen
Lauterbach, Karl Wilhelm. See Gandjour
Law, M., N. Wald, and J. Morris. Lowering blood pressure to prevent myocardial infarction and stroke: A new preventive strategy, 145
Lehoux, Pascale. See Hivon
Lehoux, Pascale, Renaldo N. Battista, Alicia Granados, Pedro Gallo, Stéphanie Tailliez, Doug Coyle, Marco Marchetti, Piero Borgia, and Gualtiero Ricciardi. International Master's Program in health technology assessment and management: Assessment of the first edition (2001–2003), 104
Lepanto, Luigi. See Paré
Lewis, S. See Wardlaw
Liao, Kai-Ping. See Kung
Liaropoulos, Lycurgus L. See Kaitelidou
Logus, Wayne. See Chuck
Longo, Mirella F. See Hutchings
Lund, Mørland. See Håheim
Lundkvist, Jonas, Bengt Jönsson, and Clas Rehnberg. Cost-effectiveness of new drugs: A systematic review of published evidence for new chemical entity drugs introduced on the Swedish market 1987-2000, 187
Lyngstadaas, Anita. See Håheim
Mackert, Michael S. See Whitten
MacLennan, G. See Grimshaw
Manca, Andrea. See Drummond
Maniadakis, Nikolaos. See Kaitelidou
Mant, J., R. J. McManus, R. A. L. Oakes, B. C. Delaney, P. M. Barton, J. J. Deeks, L. Hammersley, R. C. Davies, M. K. Davies, and F. D. R. Hobbs. Systematic review and modeling of the investigation of acute and chronic chest pain presenting in primary care, 148
Marchetti, Marco. See Lehoux
Marino, Patricia, Carole Siani, Henri Roché, and Jean-Paul Moatti for the PEGASE group. Impact of uncertainty on cost-effectiveness analysis of medical strategies: The case of high-dose chemotherapy for breast cancer patients, 342
Matowe, L. See Grimshaw
McDaid, David. See Sassi
McEwan, Alexander. See Chuck
McGahan, Lynda. See Brady
McGregor, Maurice, and James M. Brophy. End-user involvement in health technology assessment (HTA) development: A way to increase impact, 263
McManus, R. J. See Mant
Meads, Catherine, and Arie Nouwen. Does emotional disclosure have any effects? A systematic review of the literature with meta-analyses, 153
Medley, G. F. See Cooper
Meriläinen, Pirkko. See Kattainen
Messer, D. See Townsend
Michiels, Stefan, Pascal Piedbois, Sarah Burdett, Nathalie Syz, Lesley Stewart, and Jean-Pierre Pignon. Meta-analysis when only the median survival times are known: A comparison with individual patient data results, 119
Mihalopoulos, Cathrine, Dominique A. Cadilhac, Marjory L. Moodie, Helen M. Dewey, Amanda G. Thrift, Geoffrey A. Donnan, and Robert C. Carter. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke, 499
Miyazaki, Motonobu. See Babazono
Moatti, Jean-Paul. See Marino
Moga, Carmen. See Corabian
Molckovsky, Dana. See Kwok
Moodie, Marjory L. See Mihalopoulos
Morris, J. See Law
Morrissey, Matthew Charles. See Goodwin
Munafo, M. See Bankhead
Neumann, Peter J. See Sonnad
Neyt, Mattias J., Johan A. Albrecht, Bart Clarysse, and Véronique F. Cocquyt. Cost-effectiveness of Herceptin®: A standard cost model for breast-cancer treatment in a Belgian university hospital, 132
Nielsen, Torsten Toftegaard. See Terkelsen
Niessen, Louis. See Baltussen
Nørgaard, Bjarne Linde. See Terkelsen
Nouwen, Arie. See Meads
Oakes, R. A. L. See Mant
Oh, Eun-Hwan, Yuichi Imanaka, and Edward Evans. Determinants of the diffusion of computed tomography and magnetic resonance imaging, 73
Olaizola, Maite. See Aldasoro
Olsen, Jens, Ingrid Willaing, Steen Ladelund, Torben Jørgensen, Jens Gundgaard, and Jan Sørensen. Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease, 194
Packer, Claire. See Simpson
Paisley, S. See Pandor
Pandor, A., J. Eastham, C. Beverley, J. Chilcott, and S. Paisley. Clinical-effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review, 150
Paré, Guy, Luigi Lepanto, David Aubry, and Claude Sicotte. Toward a multidimensional assessment of picture archiving and communication system success, xxx
Peterburg, Yitzhak. See Greenberg
Peters, Tim J. See Flynn
Piedbois, Pascal. See Michiels
Pignon, Jean-Pierre. See Michiels
Pliskin, Joseph S. See Greenberg
Porzsolt, Franz, Hana Kajnar, Aziz Awa, Margit Fässler, and Barbara Herzberger. Validity of original studies in health technology assessment reports: Significance of standardized assessment and reporting, 410
Poulsen, Peter Bo. See Draborg
Price, Alison. See Shepherd
Putter, Hein. See van den Brink
Quist-Therson, E. See Townsend
Raftery, James. See Simpson
Raftery, James. See Stevens
Ramsay, C. R. See Grimshaw
Räsänen, Pirjo, Harri Sintonen, Olli-Pekka Ryynänen, Marja Blom, Virpi Semberg-Konttinen, and Risto P. Roine. Measuring cost-effectiveness of secondary health care: Feasibility and potential utilization of results, 22
Ratcliffe, Julie. See Goodwin
Regan, M. See Allsup
Rehnberg, Clas. See Lundkvist
Reis, Andreas. See Gandjour
Ribacoba, Laureano. See Aldasoro
Ricciardi, Gualtiero. See Lehoux
Ricciardi, Walter. See Sassi
Richardson, Gerry, Hugh Gravelle, Helen Weatherly, and Gill Ritchie. Cost-effectiveness of interventions to support self-care: A systematic review, 423
Rico, Rosa. See Aldasoro
Ritchie, Gill. See Richardson
Roberts, J. A. See Cooper
Roché, Henri. See Marino
Roderick, Paul. See Stevens
Rogers, C. See Townsend
Roine, Risto P. See Räsänen
Rosen, Allison B. See Sonnad
Round, Ali. See Stein
Rovira, Joan. See Iglesias
Russell, Ian. See Hutchings
Ryynänen, Olli-Pekka. See Räsänen
Sadat, Somayeh. See Kopach
Sandercock, P. A. G. See Wardlaw
Santos, Maria T. See Ungar
Sassi, Franco, David McDaid, and Walter RicciardiWalter. Conjoint analysis of preferences for cardiac risk assessment in primary care, 211
Sculpher, Mark. See Drummond
Semberg-Konttinen, Virpi. See Räsänen
Seymour, J. See Wardlaw
Shepherd, Jonathan, Håkan F. T. Brodin, Carolyn Backer Cave, Norman R. Waugh, Alison Price, and John Gabbay. Clinical- and Cost-Effectiveness of Pegylated Interferon Alfa in the Treatment of Chronic Hepatitis C: A Systematic Review and Economic Evaluation, 47
Shirran, L. See Grimshaw
Shmueli, Amir, and Charles L. Sprung. Assessing the in-hospital survival benefits of intensive care, 66
Siani, Carole. See Marino
Sicotte, Claude. See Paré
Siebert, Uwe, and Gaby Sroczynski. Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus Ribavirin in patients with chronic hepatitis C in Germany: A health technology assessment commissioned by the German Federal Ministry of Health and Social Security, 55
Simpson, Sue, Claire Packer, Andrew Stevens, and James Raftery. Predicting the impact of new health technologies on average length of stay: Development of a prediction framework, 487
Sintonen, Harri. See Kattainen
Sintonen, Harri. See Räsänen
Skidmore, Becky. See Brady
Sonnad, Seema S., Dan Greenberg, Allison B. Rosen, and Peter J. Neumann. Diffusion of published cost-utility analyses in the field of health policy and practice, 399
Sørensen, Jan. See Olsen
Sprangers, Mirjam A. G. See Stalmeier
Sprung, Charles L. See Shmueli
Sroczynski Gaby. See Siebert
St. Hilaire, Donald. See Chuck
Stalmeier, Peep F. M., Angela G. E. M. de Boer, Mirjam A. G. Sprangers, Hanneke C. J. M. de Haes, and Jan J. B. van Lanschot. Validity of utilities of patients with esophageal cancer, 113
Stearns, Sally C. See Gonzalez-Perez
Stein, Ken, Kim Dalziel, Ruth Garside, Emanuela Castelnuovo, and Ali Round. Association between methodological characteristics and outcome in health technology assessments which included case series, 277
Stevens, Andrew. See Simpson
Stevens, Andrew J., James Raftery, and Paul Roderick. Can health technologies be assessed using routine data?, 96
Stewart, Lesley. See Michiels
Stewart-Brown, S. See Bankhead
Stiggelbout, Anne M. See van den Brink
Stokes, Elizabeth A. See Derrett
Stone, S. P. See Cooper
Syz, Nathalie. See Michiels
Tailliez, Stéphanie. See Hivon
Tailliez, Stéphanie. See Lehoux
Tanaka, Kiyoshi. See Babazono
Tanihara, Shinichi. See Babazono
Taylor, Rebecca J., and R. S. Taylor. Spinal cord stimulation for failed back surgery syndrome: A decision-analytic model and cost-effectiveness analysis, 351
Taylor, Rod S. See R. J. Taylor
Terkelsen, Christian Juhl. Response to commentaries by Kildemoes and Kristiansen, 419
Terkelsen, Christian Juhl, Jens Flensted Lassen, Bjarne Linde Nørgaard, Torsten Toftegaard Nielsen, and Henning Rud Andersen. When analyses are invalidated by erroneous assumptions, 414
Thomas, R. E. See Grimshaw
Thornton, Judith M. See Elliott
Thrift, Amanda G. See Mihalopoulos
Thue, Geir. See Fauli
Tomlin, M. See Townsend
Torbjørn Fosen. See Håheim
Townsend, J., D. Wolke, J. Hayes, S. Davé, C. Rogers, L. Bloomfield, E. Quist-Therson, M. Tomlin, and D. Messer. Routine examination of the newborn: The EMREN Study. Evaluation of an extension of the midwife role including a randomized controlled trial of appropriately trained midwives and pediatric senior house officers, 146
Tsai, Wen-Chen. See Kung
Tsuda, Toshihide. See Babazono
Tully, Mary P. See Elliott
Une, Hiroshi. See Babazono
Ungar, Wendy J. See Kopach
Ungar, Wendy J., and Maria T. Santos. Quality appraisal of pediatric health economic evaluations, 203
Vale, L. See Grimshaw
Vale, Luke. See Gonzalez-Perez
van de Velde, Cornelis J. H. See van den Brink
van den Brink, Mandy, Wilbert B. van den Hout, Anne M. Stiggelbout, Hein Putter, Cornelius J. H. van de Velde, and Job Kievit. Self-Reports of Health-Care Utilization: Diary or Questionnaire?, 298
van den Hout, Wilbert B. See van den Brink
van Lanschot, Jan J. B. See Stalmeier
van Tulder, Maurits. See Evers
Vekstein, Daniel. See Greenberg
Wald, N. See Law
Wanke, Margaret I., and Don Juzwishin. International comparison and review of a health technology assessment skills program, 253
Wardlaw, J. M., S. L. Keir, J. Seymour, S. Lewis, P. A. G. Sandercock, M. S. Dennis, and J. Cairns. What is the best imaging strategy for acute stroke?, 148
Waugh, Norman R. See Shepherd
Weatherly, Helen. See Richardson
Weaver, Lindell. Letter to the Editor, 151
Webb, A. Kevin. See Elliott
Webster, P. See Bankhead
Wensing, M. See Grimshaw
Weston, Adèle R., Terri J. Jackson, and Stephen Blamey. Diagnosis of appendicitis in adults by ultrasonography or computed tomography: A systematic review and meta-analysis, 368
Whitten, Pamela S., and Michael S. Mackert. Addressing telehealth's foremost barrier: Provider as Initial gatekeeper, 517
Whitty, P. See Grimshaw
Willaing, Ingrid. See Olsen
Williams, John G. See Hutchings
Wolke, D. See Townsend
Wordsworth, Sarah. See Gonzalez-Perez
Yamamoto, Eiji. See Babazono
Yaung, Chih-Liang. See Kung
Zethraeus, Niklas. See Kiessling
Zethraeus, Niklas, Fredrik Borgström, Bengt Jönsson, and John Kanis. Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomized controlled trial, 433
Ziroyanis, Panagiotis N. See Kaitelidou